Total Funding
54
53
Total FundingSeries A raised
Growth Score
-2 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
29529
Gemelli is a biotechnology company that specializes in the microbiome, and IBS diagnostics.
- Ali Rezaie: Co-Founder & Inventor
- Barbra Dillon: Director Of Marketing Operations
About the Company
Gemelli is a biotechnology company that specializes in the microbiome, and IBS diagnostics. It strives to achieve a thriving global family of healthy individuals by unlocking the potential of the microbiome. The company is driven by its mission is to support the discovery of novel diagnostics and therapeutics for the human microbiome by bringing
biotechnology innovations to market in a fiscally responsible and socially conscious way.
The company was founded in 2018 and headquartered in North Carolina, United States.
Women Founded
